Search results for "Anticoagulation"


 
Results 31 - 40 of about 210 for "Anticoagulation".
Sort by: Relevance | Newest | Oldest

Tailoring anticoagulation more of a reality with DOACs

Direct oral anticoagulants have the potential to replace warfarin for the treatment of many patients with venous thromboembolism, but without a need for routine monitoring, good patient selection is key to their use.
https://acpinternist.org/archives/2018/03/tailoring-anticoagulation-more-of-a-reality-with-doacs.htm
1 Mar 2018

New-generation anticoagulants associated with bleeding after ACS in patients on antiplatelet therapy

New-generation anticoagulants are associated with increased bleeding risk when used after acute coronary syndrome (ACS) in patients taking antiplatelet agents, according to a new meta-analysis.
https://acpinternist.org/weekly/archives/2012/10/02/5.htm
2 Oct 2012

Higher CHADS2 scores can indicate higher risk in patients on anticoagulants

Higher CHADS2 scores pointed to higher risk for adverse outcomes, including stroke, bleeding and death, in patients with atrial fibrillation receiving anticoagulation, according to a new study.
https://acpinternist.org/weekly/archives/2011/11/15/5.htm
15 Nov 2011

Aspirin appears to reduce recurrence of VTE after stopping anticoagulants

Aspirin reduced the risk of venous thromboembolism (VTE) recurrence with no apparent increase in major bleeding in patients who had an initial unprovoked VTE and had discontinued anticoagulant treatment, a study found.
https://acpinternist.org/weekly/archives/2012/06/05/6.htm
5 Jun 2012

Risk of ischemic stroke may be higher in afib patients on newer anticoagulants vs. on warfarin

The increase in stroke risk was particularly high among patients taking apixaban and dabigatran, whereas the results for rivaroxaban and edoxaban were more ambiguous.
https://acpinternist.org/weekly/archives/2018/10/23/4.htm
23 Oct 2018

DOACs may be safe, effective for VTE prevention in patients with higher weight, BMI

Patients with first-time venous thromboembolism (VTE) who weighed 120 kg or more and had a body mass index (BMI) of 40 kg/m2 or more were not at higher risk for bleeding or recurrent VTE with direct-acting oral anticoagulants (DOACs) versus warfarin.
https://acpinternist.org/weekly/archives/2021/11/09/4.htm
9 Nov 2021

Approvals for an oral anticoagulant, generic esomeprazole

This update covers the approval of an oral medication to reduce the risk of stroke and embolism in atrial fibrillation and the first generic version of esomeprazole.
https://acpinternist.org/archives/2015/04/fda.htm
1 Apr 2015

Anticoagulation likely OK for stroke patients undergoing dental procedures

Stroke patients on blood thinners who undergo dental procedures can routinely continue aspirin or warfarin, according to level A recommendations issued by the American Academy of Neurology.
https://acpinternist.org/weekly/archives/2013/06/04/1.htm
4 Jun 2013

Diltiazem may increase bleeding risk when coadministered with DOACs in afib

A study of patients with atrial fibrillation in one U.S. health system found a 56% higher risk for bleeding-related hospitalization associated with concomitant use of diltiazem and a direct-acting oral anticoagulant (DOAC) versus a DOAC alone.
https://acpinternist.org/weekly/archives/2022/07/12/5.htm
12 Jul 2022

Self-testing, self-dosage for anticoagulation safe, suitable option for some patients, study indicates

Self-testing and self-dosage of oral anticoagulation may be safe and suitable for patients of all ages with suitable health care support as backup, according to a meta-analysis.
https://acpinternist.org/weekly/archives/2011/12/06/1.htm
6 Dec 2011

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next